AEON AEON Biopharma, Inc.
$0.25▲ +3.46%
Healthcare
Other
Volume 139.8K
Avg Volume (10D) 438.0K
Key Metrics & Fundamentals
Market Cap
$12.39M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.18 - 1.45
% vs 50 MA
-3.12%
% vs 200 MA
-63.98%
RSI-14
47.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.55
Free Cash Flow
-$3.70M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$10.65M
COGS
–
Operating Exp
$5.93M
Operating Income
-$5.93M
EBIT
-$5.93M
Pretax Income
-$1.16M
Net Income
-$1.16M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
AEON Biopharma Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
GlobeNewswire · Oct 9, 2026 4:15 PM ET
AEON: Initiating Coverage – Imitation is a Sincere Form of Flattery: Seeking a Botox Biosimilar
Zacks Small Cap Research · Oct 5, 2026 5:36 AM ET
AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450
GlobeNewswire · Sep 30, 2026 8:00 AM ET
Top Premarket Gainers
MT Newswires · Sep 10, 2026 7:10 AM ET
AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®
GlobeNewswire · Sep 9, 2026 8:00 AM ET
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
GlobeNewswire · Aug 24, 2026 8:00 AM ET
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®
GlobeNewswire · Aug 19, 2026 8:00 AM ET
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 12, 2026 4:15 PM ET
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards
GlobeNewswire · Aug 3, 2026 4:15 PM ET
Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls
The Fly · Jul 30, 2026 9:38 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AEON's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.